Showing results (291-300 of 522) with videos related to

Sort By:
Pageof 53
Cancer Chemotherapy and Pharmacology|August 4, 2009
Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinomaPaul Haluska, Frank Worden, David Olmos, et al.
Human Molecular Genetics|November 13, 2004
Urogenital and caudal dysgenesis in adrenocortical dysplasia (acd) mice is caused by a splicing mutation in a novel telomeric regulatorCatherine E Keegan, Janna E Hutz, Tobias Else, et al.
Nature Structural & Molecular Biology|July 17, 2007
Telomere protection by mammalian Pot1 requires interaction with Tpp1Dirk Hockemeyer, Wilhelm Palm, Tobias Else, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 22, 2020
The Effect of Biochemical Remission on Bone Metabolism in Cushing's Syndrome: A 2-Year Follow-Up StudyLeah T Braun, Julia Fazel, Stephanie Zopp, et al.
The Journal of Clinical Endocrinology and Metabolism|November 9, 2019
Patients With Primary Aldosteronism Respond to Unilateral Adrenalectomy With Long-Term Reduction in Salt IntakeChristian Adolf, Daniel A Heinrich, Finn Holler, et al.
Nature Communications|April 5, 2020
β-Catenin and FGFR2 regulate postnatal rosette-based adrenocortical morphogenesisSining Leng, Emanuele Pignatti, Radhika S Khetani, et al.
Hypertension (Dallas, Tex. : 1979)|December 25, 2018
Proteomic Landscape of Aldosterone-Producing AdenomaMarta M Swierczynska, Matthias J Betz, Marco Colombi, et al.
European Journal of Endocrinology|August 28, 2015
Increased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Conn's RegistryGregor Hanslik, Henri Wallaschofski, Anna Dietz, et al.
The Journal of Clinical Endocrinology and Metabolism|April 13, 2019
Plasma Steroid Profiles in Subclinical Compared With Overt Adrenal Cushing SyndromeJimmy Masjkur, Matthias Gruber, Mirko Peitzsch, et al.
Pageof 53